Alzheimer's Disease Trial, Recruiting NCT03592563 Sponsor: Chinese University of Hong Kong Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT03592563
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People who fit into one of three groups: the Red group (already diagnosed with one or more neurological and/or psychiatric conditions), the Yellow group (considered at high risk of developing one or more neurological and/or psychiatric conditions), or the Green group (not in the Red or Yellow groups, but interested in long-term research on maintaining or improving brain health).
  • For the Yellow group, high risk may be based on having a close family member (parent, sibling, or child) with one or more neurological and/or psychiatric conditions, or having test results, scans, or physical findings that suggest early stages of such a condition before symptoms appear.
  • People who agree to participate by signing and dating a written consent form.
  • People who are willing to complete health questionnaires and be followed over a period of time.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • No exclusion criteria have been listed for this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas Wai Hong LEUNG, FRCP, Division of Neurology, The Chinese University of Hong Kong

Phone: 852-35053593

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2019
Est. completion
31 December 2038

Where this trial is recruiting

Hong Kong

Primary endpoints

Risk factors contributing to neurological and psychiatric diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov